2024 Rome, Italy

II-009 Antonio Goncalves
Operating characteristics of TGI metrics to support early Phase Ib decisions in unresectable hepatocellular carcinoma patients based on an historical Phase III study (IMbrave150)
Wednesday 15:20-16:50